Actionable news
All posts from Actionable news
Actionable news in XOMA: XOMA Corporation,

XOMA starts mid-stage study of XOMA 358 in congenital hyperinsulinism; shares up 27%

Micro cap (XOMA +27.1%) is up on a 7x surge volume due, at least in part, to short covering. Yesterday, the company announced that it initiated a Phase 2 proof-of-concept clinical trial evaluating...